Patents by Inventor Ahlke Heydemann

Ahlke Heydemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20230235044
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: July 7, 2022
    Publication date: July 27, 2023
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20220089717
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: November 29, 2021
    Publication date: March 24, 2022
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20210238274
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: March 31, 2021
    Publication date: August 5, 2021
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20200385457
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: August 14, 2020
    Publication date: December 10, 2020
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20200123247
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: December 16, 2019
    Publication date: April 23, 2020
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4)
    Publication number: 20190256589
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 22, 2019
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20190002557
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: September 5, 2018
    Publication date: January 3, 2019
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4)
    Publication number: 20180134785
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: December 28, 2017
    Publication date: May 17, 2018
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)
    Patent number: 9873739
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a Transforming Growth Factor-beta (TGF?) superfamily protein.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: January 23, 2018
    Assignee: Ikaika Therapeutics, LLC
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco
  • MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
    Publication number: 20140037637
    Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a TGF? superfamily protein.
    Type: Application
    Filed: August 1, 2013
    Publication date: February 6, 2014
    Inventors: Elizabeth McNally, Ahlke Heydemann, Ermelinda Ceco